Prevail Therapeutics Competitors and Similar CompaniesClear all
Y-mAbs Therapeutics's competitors and similar companies include Thor Medical.
 Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. |  Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. | |
Founding Date | Founding Date 2014 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Copenhagen, DK Nutley, US | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB |
Employees | Employees 3239% increase | Employees 3716% decrease |
Valuation ($) | Valuation ($) 657 m | Valuation ($) 131.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $87.7m (FY, 2024) | Revenue (est.) kr439k (FY, 2025) |
Cost of goods | Cost of goods $15m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $72.7m (FY, 2024) | Gross profit kr4.3m (FY, 2025) |
Net income | Net income ($29.7m) (FY, 2024) | Net income (kr58m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Thor Medical
HQ
Oslo, NO
Employees
37↓ 16% decrease
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View company